Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-22

FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approves a supplemental application for the ezetimibe and simvastatin combination by Amneal, indicating a modification to an already-approved product (such …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE AND SIMVASTATIN (ezetimibe and simvastatin)

Snippet

SUPPL AP for EZETIMIBE AND SIMVASTATIN (EZETIMIBE AND SIMVASTATIN)